Academic publisher Oxford University Press (OUP) has announced its partnership with Duke University, Harvard Law School, and Stanford University to launch a new open access journal in 2014 - Journal of Law and the Biosciences (JLB).
JLB is projected to become the preeminent outlet to publish cutting-edge scholarship wherever law and the biosciences intersect. The JLB will take a broad and interdisciplinary view of its area, publishing articles on topics generally considered part of bioethics or neuroethics, such as the ethical, legal, and social implications of reproductive technologies, genetics, stem cell research, neuroscience, or human biological enhancement. At the same time, it will be a home for work that speaks directly to legal issues where the biosciences can be involved, such as food and drug regulation, biosciences patent law, scientific evidence, and criminal responsibility.
The JLB’s initial co-editors in chief are I. Glenn Cohen from Harvard, Nita Farahany from Duke, and Hank Greely from Stanford. The journal will also be assisted by an editorial board. The current board comprises nearly thirty leading scholars working in the area of law, bioethics, philosophy, neuroscience, psychology, and other disciplines.
The JLB is an open access journal. Authors will have the choice of publishing under either a Creative Commons Attribution Non-Commercial No-Derivs (CC-BY-NC-ND), or a Creative Commons Attribution (CC-BY) license. Authors electing to publish under CC-BY will be required to pay an article processing charge (APC).
